Not Yet Recruiting
Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis
NCT07565701
- Conditions
- Anemia Associated With Chronic Kidney Disease
- Locations
-
Not specified